- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Digital Phenotype Could Change Healthcare
The "digital phenotype," a catch-all term for the trail of relevant health data people leave behind in their interactions with the internet, social media, and technology, has largely untapped potential for the early detection of various conditions.
A new editorial in Nature Biotech poses the idea of the “digital phenotype” as a catch-all term for the trail of relevant health data people leave behind in their interactions with the internet, social media, and technology, which has largely untapped potential for the early detection of various conditions.
CareMore Chief Medical Officer Sachin Jain, MD, submitted the paper along with Harvard Medical School colleagues Brian Powers, an MD candidate, Jared Hawkins, PhD, and John Brownstein, PhD, whose Computational Epidemiology Group has done a lot of work in the area of digital phenotyping already.
“People are increasingly leaving a footprint of their health status through technology, including social media, forums, online communities, wearable technologies, and mobile devices,” Dr Jain said in a statement. “This information all has clinical value to a physician. The challenge is being aware of it and knowing how to access and interpret it.”
Read more at MobiHealthNews: http://bit.ly/1bMrKBU
Niraparib Extends PFS, Time to Next Treatment in Patients With EOC, Especially BRCA-Mutated Cases
January 28th 2025First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment (rwTTNT) in patients with epithelial ovarian cancer (EOC), with the greatest benefit observed in those considered homologous recombination-deficient (HRd) and those with BRCA-mutated (BRCAm) tumors.
Read More
